MTBT
Product Specifications
UNSPSC Description
MTBT is an anticancer agent and p38 activator with antiproliferative and apoptosis-inducing (apoptosis) activities. MTBT increases the phosphorylation of histone H3 serine in cancer cells, thereby arresting the cell cycle in the M phase. SB203580 (HY-10256), a specific inhibitor of p38 MAPK, abolished MTBT-induced cell cycle arrest[1].
Target Antigen
p38 MAPK
Type
Reference compound
Related Pathways
MAPK/ERK Pathway
Field of Research
cancer
Assay Protocol
https://www.medchemexpress.com/mtbt.html
Purity
99.60
Smiles
OC1=CC=C(C=C1O)C2=CSC(C3=C(C=CS3)C)=N2
Molecular Weight
289.37
References & Citations
[1]A small molecule, MTBT, prevents cancer cell growth by activating p38 MAPK
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-118034/MTBT-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-118034/MTBT-SDS-MedChemExpress.pdf
Clinical Information
No Development Reported
CAS Number
1110905-26-4
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6345415-01 0.2 mL
SCRIB, NT (SCRIB, CRIB1, KIAA0147, LAP4, SCRB1, VARTUL, Protein scribble homolog, Protein LAP4) (AP)
Ask
View Details 
MBS6345415-02 5x 0.2 mL
SCRIB, NT (SCRIB, CRIB1, KIAA0147, LAP4, SCRB1, VARTUL, Protein scribble homolog, Protein LAP4) (AP)
Ask
View Details